Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the benefits can be seen in multiple ways, a new study ... Nov. 19, 2024 — A recently published study ...

Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...

Parkinson's disease is characterized by a collection of uniquely distinguishing symptoms that affect movement and a number of other aspects of daily life. These include, but are not limited to, ...

Symptoms of Parkinson's disease typically appear gradually and worsen over time. Symptoms and the speed of progression vary from person to person. Early detection of Parkinson's can help people ...

Dancing was found to reduce depression associated with Parkinson's disease, with benefits observed in multiple ways (1 Trusted Source Impact of Weekly Community-Based Dance Training Over 8 ...

If you have Parkinson’s disease, you probably realize that all of your relationships – those with your spouse, partner, family, friends, colleagues, and acquaintances – can change. They can change in ...

Women with TMJ-related pain tend to have poorer sleep quality and often experience insomnia and sleep apnea, per a 2014 study in the Journal of Clinical Sleep Medicine.

A decline in motor skills is a hallmark of Parkinson's disease, regularly taking the form of slowness, rigidity, and tremors. Yet the condition commonly affects other neurological functions as well, ...

Patients often say they have TMJ – which is the joint – when they ... Other causes of TMD include Alzheimer’s disease, Parkinson’s, brain injury or sleep apnoea (a disorder which causes ...

The temporomandibular joint (TMJ) is the hinge-like bone that connects your jaw and your skull. You can feel it moving by pressing your index fingers to your cheeks and opening and closing your mouth.

Researchers have discovered a new biomarker for Parkinson’s that could be used to identify people at risk of the disease and profoundly change the way it is treated. The assay for a particular ...

AbbVie has completed a hat trick of phase 3 wins for its Parkinson’s disease prospect tavapadon, teeing the drugmaker up to file for FDA approval in 2025. The Big Pharma acquired the once-daily ...